Astra Buying Bristol Makes No Sense, Fazeli Says
AstraZeneca shares plunged Monday on news that the drugmaker was exploring an acquisition of Bristol Meyers Squibb. A deal would create one of the world's biggest drugmakers. Sam Fazeli of Bloomberg Intelligence says a takeover would make no sense.
More from Australia
Productivity Commission proposes cutting business reporting rules
Aussie government to introduce super advice laws next week
Argenica’s US stroke trial stalls as FDA demands rat brain study
Echo IQ shares sink 42% as FDA upholds rejection
Australian Vintage names new CFO, starting January 2027
ASIC warns on QUFC Exchange, removes 20+ websites